// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Neuropsychological assessment of diverse populations in Europe: The European Consortium for Cross-Cultural Neuropsychology (ECCroN)

Sanne Franzen - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dual pathogenic mutations in SQSTM1 and C9orf72 as a cause of frontotemporal dementia

Hanya Benotmane - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

Classification of AD/MCI/HC based on amyloid-PET using Random Forest Ensemble

Yiwen Bao - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

CSF amyloid, tau, and neurodegeneration biomarkers are associated with longitudinal cognitive decline in preclinical AD

Karly Alex Cody - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

CSF and PET biomarkers for noradrenergic dysfunction in neurodegenerative disease: a systematic review and meta-analysis.

Elisa Lancini - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Norepinephrine topical

Early Onset Dementia: Clinical utility of cerebrospinal fluid Amyloidβ and tau measures in diagnosing mild cognitive impairment

Akram A. Hosseini - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Capturing functional change in early Alzheimer’s disease: Comparing instruments and scoring techniques to detect subtle decline

Mark A. Dubbelman - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Accelerated long-term forgetting: prognostic utility in Familial Alzheimer’s Disease

Duncan Alston - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Evidence for the role of semantic cueing and executive functioning tools in early and differential diagnosis of Neurocognitive Disorder (NCD): a neuropsychological approach

Chiara Abbatantuono - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort

Phoebe H Foster - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

Eye-tracking task detects early executive function deficits in presymptomatic frontotemporal dementia

Lucy L Russell - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

Memory Assessment and Dementia Risk in the PREVENT Study

Mario A Parra-Rodriguez - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Dementia

N/A

The Boston Naming Test identifies presymptomatic anomia in MAPT mutation carriers

Arabella Bouzigues - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Frontotemporal dementia

N/A

The risk of cognitive impairment in spouses of patients with cognitive impairment

Jee Hyang Jeong - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Alzheimer's disease

N/A

Alzheimer’s Disease Genetic Risk Variants Show Brain Cell Type-specific Associations with Protein levels in Cerebrospinal Fluid

Lianne M. Reus - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Exome-wide rare variant analysis of Alzheimer’s disease biomarkers: the EMIF-AD multimodal biomarker discovery study

Alexander Neumann - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

An integrated systems-level analysis of the molecular changes resulting from systemic inflammation in Alzheimer’s disease

Lachlan Ford MacBean - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Systemic inflammation

N/A

A role for epigenetic mechanisms in the Lewy Body Dementias

Jennifer L Imm - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Targeted bisulfite sequencing analysis of candidate genes associated with Alzheimer’s disease.

Greg Wheildon - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Mild cognitive impairment

N/A

Hippocampal maintenance after a 12-month physical activity intervention in older adults: the REACT MRI study

Naiara Demnitz - Alzheimer's Association International Conference (AAIC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved